MoonLake Immunotherapeutics Class A (MLTX) Stock: News, Analysis, Q&A, and Insights

Investment Analysis Report: MLTX

Overview

In this investment analysis report, we will delve into a comprehensive evaluation of MLTX, a company operating in the Health Technology sector within the Pharmaceuticals: Major industry. We will analyze the company's financial health, earnings and revenue growth, profitability, operating margin, operatin...

Technical Analysis of MLTX 2024-05-03

Overview:

In analyzing the technical indicators for MLTX over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive assessment of the stock's potential price movement. By examining these key factors, we aim to offer valuable insights and predictions for the next few days.

Trend Anal...

Recent News & Updates

2024-05-07 21:02
MoonLake Immunotherapeutics Reports Q1 2024 Financial Outcomes(GuruFocus.com)
2024-05-07 10:15
MoonLake Immunotherapeutics Q1 Net Loss Widens(MT Newswires)
2024-05-07 08:00
MoonLake Immunotherapeutics Reports First Quarter 2024 Financial Results and Provides a Business Update(GlobeNewswire)
2024-05-07 01:53
MLTX Stock Earnings: MoonLake Misses EPS for Q1 2024(Investorplace)
2024-05-06 20:00
MoonLake Immunotherapeutics Reports First Quarter 2024 Financial Results and Provides a Business Update(Globenewswire)
2024-04-10 07:00
MoonLake Immunotherapeutics Inks Three-Year Technology Partnership With Komodo Health To Advance Research on Inflammatory Skin and Joint Conditions(Business Wire)
2024-04-09 19:00
MoonLake Immunotherapeutics inks three-year technology partnership with Komodo Health to advance research on inflammatory skin and joint conditions(Globenewswire)
2024-03-15 11:36
MoonLake Immunotherapeutics (NASDAQ:MLTX) Is In A Strong Position To Grow Its Business(Simply Wall St.)
2024-03-11 10:41
MoonLake Jumps After Arthritis Drug Tops AbbVie Blockbuster Humira In A Key Test(Investor's Business Daily)
2024-03-10 12:00
MoonLake announces significant improvements with Nanobody® sonelokimab over 24 weeks in active psoriatic arthritis (PsA) and other important updates at its R&D Day(GlobeNewswire)
2024-03-09 23:00
MoonLake announces significant improvements with Nanobody sonelokimab over 24 weeks in active psoriatic arthritis (PsA) and other important updates at its R&D Day(Globenewswire)
2024-03-04 08:00
MoonLake Immunotherapeutics to present MIRA trial data of Nanobody® sonelokimab in hidradenitis suppurativa as a late breaker at the AAD Annual Meeting 2024(GlobeNewswire)
2024-03-03 19:00
MoonLake Immunotherapeutics to present MIRA trial data of Nanobody sonelokimab in hidradenitis suppurativa as a late breaker at the AAD Annual Meeting 2024(Globenewswire)
2024-03-01 00:38
Insider Sell: CEO Santos da Silva Jorge Sells 123,615 Shares of MoonLake Immunotherapeutics (MLTX)(GuruFocus.com)
2024-02-29 08:00
MoonLake Immunotherapeutics Reports Full Year 2023 Financial Results, Recent Business Highlights and Announces an R&D Day on March 10(GlobeNewswire)
2024-02-28 19:00
MoonLake Immunotherapeutics Reports Full Year 2023 Financial Results, Recent Business Highlights and Announces an R&D Day on March 10(Globenewswire)
2024-02-26 08:00
MoonLake Immunotherapeutics Announces Positive Feedback from both FDA and EMA on Regulatory Path for the Phase 3 Program of the Nanobody® sonelokimab (SLK) in Hidradenitis Suppurativa (HS)(GlobeNewswire)
2024-02-25 19:00
MoonLake Immunotherapeutics Announces Positive Feedback from both FDA and EMA on Regulatory Path for the Phase 3 Program of the Nanobody sonelokimab (SLK) in Hidradenitis Suppurativa (HS)(Globenewswire)
2024-02-20 23:44
Insider Sell: CEO Santos da Silva Jorge Sells 60,000 Shares of MoonLake Immunotherapeutics(GuruFocus.com)
2024-01-11 09:55
Wall Street Analysts Believe MoonLake Immunotherapeutics (MLTX) Could Rally 26.97%: Here's is How to Trade(Zacks)
2024-01-10 20:55
Wall Street Analysts Believe MoonLake Immunotherapeutics (MLTX) Could Rally 26.97%: Here's is How to Trade(Zacks)
2024-01-10 08:42
Is MoonLake Immunotherapeutics (MLTX) Stock a Solid Choice Right Now?(Zacks)
2023-12-22 15:01
CFO Matthias Bodenstedt Sells 100,000 Shares of MoonLake Immunotherapeutics(GuruFocus.com)
2023-11-14 12:13
MoonLake Immunotherapeutics (MLTX) Posts Q3 2023 Results: Clinical Progress Amid Controlled Expenses(GuruFocus.com)
2023-11-14 08:00
MoonLake Immunotherapeutics Reports Third Quarter 2023 Financial Results and Provides a Business Update(GlobeNewswire)
2023-11-13 19:00
MoonLake Immunotherapeutics Reports Third Quarter 2023 Financial Results and Provides a Business Update(globenewswire)
2023-11-06 16:03
Why Former Highflier MoonLake Plummeted 29% After A Recent Run(Investor's Business Daily)
2023-11-05 20:46
Top-Rated MoonLake Stock Crashes On Mixed Test Results For Arthritis Drug(Yahoo Finance)
2023-11-05 11:00
MoonLake Immunotherapeutics announces landmark Phase 2 results for Nanobody® sonelokimab in active psoriatic arthritis(GlobeNewswire)
2023-11-04 23:00
MoonLake Immunotherapeutics announces landmark Phase 2 results for Nanobody sonelokimab in active psoriatic arthritis(globenewswire)

Page 1 of 3

previousnext

Home

Market Lens

Ideas Explorer

History

Recent Activity

MLTX

Performance

Profile